Concepts (111)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Radiosurgery | 4 | 2024 | 147 | 0.930 |
Why?
|
| Pain | 2 | 2012 | 461 | 0.530 |
Why?
|
| Carcinoma, Renal Cell | 2 | 2024 | 246 | 0.500 |
Why?
|
| Bone Neoplasms | 2 | 2012 | 445 | 0.470 |
Why?
|
| Kidney Neoplasms | 2 | 2024 | 453 | 0.430 |
Why?
|
| Rectal Neoplasms | 2 | 2016 | 81 | 0.400 |
Why?
|
| Urology | 2 | 2024 | 87 | 0.400 |
Why?
|
| Professional Practice Location | 1 | 2012 | 8 | 0.390 |
Why?
|
| Professional Practice | 1 | 2012 | 41 | 0.380 |
Why?
|
| Radiation Oncology | 1 | 2012 | 28 | 0.380 |
Why?
|
| Radiotherapy, Computer-Assisted | 1 | 2009 | 3 | 0.320 |
Why?
|
| Tomography, Spiral Computed | 1 | 2009 | 15 | 0.320 |
Why?
|
| Radiotherapy, Conformal | 1 | 2009 | 63 | 0.310 |
Why?
|
| Head and Neck Neoplasms | 2 | 2025 | 615 | 0.290 |
Why?
|
| Health Services Accessibility | 1 | 2012 | 656 | 0.260 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2012 | 1303 | 0.230 |
Why?
|
| Employment | 1 | 2025 | 68 | 0.230 |
Why?
|
| Delphi Technique | 1 | 2024 | 240 | 0.190 |
Why?
|
| Metformin | 1 | 2023 | 165 | 0.180 |
Why?
|
| Consensus | 1 | 2024 | 656 | 0.170 |
Why?
|
| Stress, Psychological | 1 | 2025 | 577 | 0.160 |
Why?
|
| Caregivers | 1 | 2025 | 598 | 0.160 |
Why?
|
| Carcinoma, Small Cell | 1 | 2019 | 42 | 0.150 |
Why?
|
| Dose-Response Relationship, Radiation | 2 | 2009 | 68 | 0.150 |
Why?
|
| Acute Lung Injury | 1 | 2018 | 68 | 0.140 |
Why?
|
| Uterine Cervical Neoplasms | 1 | 2020 | 261 | 0.130 |
Why?
|
| Lung Injury | 1 | 2018 | 123 | 0.130 |
Why?
|
| Colonic Neoplasms | 1 | 2019 | 264 | 0.120 |
Why?
|
| Hospitals, Public | 1 | 2016 | 44 | 0.120 |
Why?
|
| Time Factors | 4 | 2016 | 6455 | 0.120 |
Why?
|
| Transurethral Resection of Prostate | 1 | 2014 | 8 | 0.110 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2020 | 764 | 0.110 |
Why?
|
| Urination Disorders | 1 | 2014 | 22 | 0.110 |
Why?
|
| Urethra | 1 | 2014 | 90 | 0.110 |
Why?
|
| Time-to-Treatment | 1 | 2016 | 210 | 0.110 |
Why?
|
| Prognosis | 3 | 2019 | 5009 | 0.110 |
Why?
|
| Radiotherapy, Adjuvant | 1 | 2014 | 166 | 0.110 |
Why?
|
| Radiation Injuries | 1 | 2014 | 158 | 0.100 |
Why?
|
| Geographic Information Systems | 1 | 2012 | 42 | 0.100 |
Why?
|
| Group Practice | 1 | 2012 | 12 | 0.100 |
Why?
|
| Ownership | 1 | 2012 | 35 | 0.090 |
Why?
|
| Survival Rate | 2 | 2019 | 2187 | 0.090 |
Why?
|
| Statistics, Nonparametric | 1 | 2012 | 440 | 0.090 |
Why?
|
| Cranial Irradiation | 1 | 2010 | 72 | 0.080 |
Why?
|
| Femur Head | 1 | 2009 | 7 | 0.080 |
Why?
|
| Clinical Trials, Phase II as Topic | 1 | 2009 | 89 | 0.080 |
Why?
|
| Body Height | 1 | 2010 | 227 | 0.080 |
Why?
|
| Humans | 14 | 2025 | 132334 | 0.080 |
Why?
|
| Pelvis | 1 | 2009 | 72 | 0.080 |
Why?
|
| Rectum | 1 | 2009 | 114 | 0.070 |
Why?
|
| Chemoradiotherapy | 2 | 2020 | 125 | 0.070 |
Why?
|
| Urinary Bladder | 1 | 2009 | 257 | 0.070 |
Why?
|
| Texas | 2 | 2016 | 3628 | 0.070 |
Why?
|
| Intestine, Small | 1 | 2009 | 315 | 0.070 |
Why?
|
| Hydroxycholecalciferols | 1 | 2006 | 6 | 0.070 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2009 | 390 | 0.070 |
Why?
|
| Brachytherapy | 2 | 2020 | 95 | 0.060 |
Why?
|
| Receptors, Calcitriol | 1 | 2006 | 61 | 0.060 |
Why?
|
| Computer Simulation | 1 | 2009 | 697 | 0.060 |
Why?
|
| Prostatic Neoplasms | 1 | 2014 | 1577 | 0.060 |
Why?
|
| Palliative Care | 1 | 2008 | 457 | 0.050 |
Why?
|
| Neoplasm Staging | 2 | 2019 | 1367 | 0.050 |
Why?
|
| Neoplasms | 1 | 2018 | 2944 | 0.050 |
Why?
|
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2010 | 816 | 0.050 |
Why?
|
| Receptors, Estrogen | 1 | 2006 | 741 | 0.050 |
Why?
|
| Europe | 1 | 2024 | 373 | 0.050 |
Why?
|
| Follow-Up Studies | 1 | 2012 | 5405 | 0.050 |
Why?
|
| Neoplasm Metastasis | 1 | 2024 | 725 | 0.040 |
Why?
|
| Longitudinal Studies | 1 | 2025 | 1502 | 0.040 |
Why?
|
| Antineoplastic Agents | 2 | 2020 | 1829 | 0.040 |
Why?
|
| Aged | 3 | 2025 | 21379 | 0.040 |
Why?
|
| Drug Therapy | 1 | 2019 | 87 | 0.040 |
Why?
|
| Cisplatin | 1 | 2020 | 281 | 0.040 |
Why?
|
| Radiotherapy | 1 | 2019 | 145 | 0.040 |
Why?
|
| Disease Progression | 1 | 2024 | 2227 | 0.030 |
Why?
|
| Middle Aged | 3 | 2025 | 28888 | 0.030 |
Why?
|
| General Surgery | 1 | 2019 | 216 | 0.030 |
Why?
|
| Male | 5 | 2025 | 65052 | 0.030 |
Why?
|
| Adult | 3 | 2025 | 31618 | 0.030 |
Why?
|
| Combined Modality Therapy | 1 | 2019 | 1297 | 0.030 |
Why?
|
| Surveys and Questionnaires | 1 | 2025 | 3980 | 0.030 |
Why?
|
| Urogenital System | 1 | 2014 | 35 | 0.030 |
Why?
|
| Databases, Factual | 1 | 2019 | 1230 | 0.030 |
Why?
|
| Breast Neoplasms | 1 | 2006 | 2683 | 0.030 |
Why?
|
| Retrospective Studies | 2 | 2023 | 17363 | 0.030 |
Why?
|
| Prostatic Hyperplasia | 1 | 2014 | 117 | 0.030 |
Why?
|
| Quality Indicators, Health Care | 1 | 2016 | 227 | 0.030 |
Why?
|
| Treatment Outcome | 1 | 2009 | 13016 | 0.030 |
Why?
|
| Constriction, Pathologic | 1 | 2014 | 235 | 0.030 |
Why?
|
| Female | 4 | 2025 | 70786 | 0.020 |
Why?
|
| Quality of Health Care | 1 | 2016 | 418 | 0.020 |
Why?
|
| Prospective Studies | 1 | 2023 | 6540 | 0.020 |
Why?
|
| Laser Therapy | 1 | 2014 | 232 | 0.020 |
Why?
|
| Disease Management | 1 | 2016 | 565 | 0.020 |
Why?
|
| Aged, 80 and over | 1 | 2019 | 7111 | 0.020 |
Why?
|
| Severity of Illness Index | 1 | 2014 | 3087 | 0.020 |
Why?
|
| Tumor Cells, Cultured | 1 | 2006 | 1047 | 0.010 |
Why?
|
| Young Adult | 1 | 2019 | 9945 | 0.010 |
Why?
|
| Transfection | 1 | 2006 | 999 | 0.010 |
Why?
|
| Cell Cycle | 1 | 2006 | 611 | 0.010 |
Why?
|
| United States | 1 | 2019 | 11627 | 0.010 |
Why?
|
| Receptors, Progesterone | 1 | 2006 | 681 | 0.010 |
Why?
|
| Gene Expression | 1 | 2006 | 1564 | 0.010 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2006 | 816 | 0.010 |
Why?
|
| Risk Factors | 1 | 2014 | 10910 | 0.010 |
Why?
|
| Cell Proliferation | 1 | 2006 | 2512 | 0.010 |
Why?
|
| Animals | 1 | 2018 | 34989 | 0.010 |
Why?
|
| Infant | 1 | 2010 | 13192 | 0.010 |
Why?
|
| Child, Preschool | 1 | 2010 | 14851 | 0.010 |
Why?
|
| Adolescent | 1 | 2010 | 20552 | 0.010 |
Why?
|
| Child | 1 | 2010 | 25823 | 0.000 |
Why?
|